17beta-alkyl-17alpha-oxy-estratrienes

Details for Australian Patent Application No. 2010256035 (hide)

Owner Bayer Pharma Aktiengesellschaft

Inventors Bohlmann, Rolf; Heinrich, Nikolaus; Hubner, Jan; Kettschau, Georg; Kunzer, Hermann; Lienau, Philip; Gerisch, Michael; Kohr, Silke; Lang, Dieter; Denner, Karsten; Sander, Michael; Hoffmann, Jens; Wintermantel, Tim

Agent Davies Collison Cave

Pub. Number AU-A-2010256035

PCT Pub. Number WO2010/139411

Priority 09075249.4 04.06.09 EP

Filing date 26 May 2010

Wipo publication date 9 December 2010

International Classifications

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

C07J 3/00 (2006.01) Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by one carbon atom

Event Publications

22 December 2011 PCT application entered the National Phase

  PCT publication WO2010/139411 Priority application(s): WO2010/139411

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010256048-Use of stem cells from hair root sheaths and keratinocyte precursor cells for regenerating aged skin

2010256031-Product having bioresorbable carrier materials and packaging